These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3324261)
1. [Trypanosa: enzyme and immunotherapy?]. Schweiz Rundsch Med Prax; 1987 Oct; 76(42):1176-8. PubMed ID: 3324261 [No Abstract] [Full Text] [Related]
2. Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited. Gabrilovich DI Lancet Oncol; 2007 Jan; 8(1):2-3. PubMed ID: 17196504 [No Abstract] [Full Text] [Related]
3. Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy. Mathé G; Reizenstein P; Eriguchi M Suppl J Med Oncol Tumor Pharmacother; 1988; 1():75-92. PubMed ID: 3074229 [No Abstract] [Full Text] [Related]
4. Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy. Darani HY; Yousefi M Future Oncol; 2012 Dec; 8(12):1529-35. PubMed ID: 23231515 [TBL] [Abstract][Full Text] [Related]
5. Promising immunotherapy technique. Fillon M J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382 [No Abstract] [Full Text] [Related]
15. Immunotherapeutic strategies for neoplasia. Talmadge JE Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659 [No Abstract] [Full Text] [Related]
16. Highlights of the Second International Symposium on Genetic Anticancer Agents. Gerritsen WR; Krul MR Cancer Gene Ther; 2001 Sep; 8(9):678-80. PubMed ID: 11593338 [No Abstract] [Full Text] [Related]
18. The inducers of immunogenic cell death for tumor immunotherapy. Li X Tumori; 2018; 104(1):1-8. PubMed ID: 28967094 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Cancer. Preface. Wang XY; Fisher PB Adv Cancer Res; 2015; 128():xiii-xv. PubMed ID: 26216638 [No Abstract] [Full Text] [Related]
20. Biotechnological Production of Anti-cancer Compounds. Malik S Curr Med Chem; 2018; 25(36):4654-4655. PubMed ID: 30563439 [No Abstract] [Full Text] [Related] [Next] [New Search]